Literature DB >> 17603533

Microbes have the last word. A drastic re-evaluation of antimicrobial treatment is needed to overcome the threat of antibiotic-resistant bacteria.

Julian Davies1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17603533      PMCID： PMC1905906          DOI： 10.1038/sj.embor.7401022

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  26 in total

Review 1.  Why is big Pharma getting out of antibacterial drug discovery?

Authors:  Steven J Projan
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

2.  Trends in antimicrobial drug development: implications for the future.

Authors:  Brad Spellberg; John H Powers; Eric P Brass; Loren G Miller; John E Edwards
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

3.  Mobile gene cassettes: a fundamental resource for bacterial evolution.

Authors:  Carolyn A Michael; Michael R Gillings; Andrew J Holmes; Lesley Hughes; Nigel R Andrew; Marita P Holley; H W Stokes
Journal:  Am Nat       Date:  2004-05-03       Impact factor: 3.926

4.  A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons.

Authors:  H W Stokes; R M Hall
Journal:  Mol Microbiol       Date:  1989-12       Impact factor: 3.501

5.  Vicious circles: looking back on resistance plasmids.

Authors:  J Davies
Journal:  Genetics       Date:  1995-04       Impact factor: 4.562

6.  Conjugative plasmids in bacteria of the 'pre-antibiotic' era.

Authors:  V M Hughes; N Datta
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962

7.  Integron diversity in heavy-metal-contaminated mine tailings and inferences about integron evolution.

Authors:  D R Nemergut; A P Martin; S K Schmidt
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

8.  Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria.

Authors:  R Benveniste; J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

9.  Plasmids of the same Inc groups in Enterobacteria before and after the medical use of antibiotics.

Authors:  N Datta; V M Hughes
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

10.  In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.

Authors:  Sandra Chibani-Chennoufi; Josette Sidoti; Anne Bruttin; Elizabeth Kutter; Shafiq Sarker; Harald Brüssow
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191
View more
  37 in total

1.  Do we need new antibiotics? The search for new targets and new compounds.

Authors:  Jaroslav Spížek; Jitka Novotná; Tomáš Rezanka; Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2010-11-18       Impact factor: 3.346

2.  Selective advantage of resistant strains at trace levels of antibiotics: a simple and ultrasensitive color test for detection of antibiotics and genotoxic agents.

Authors:  Anne Liu; Amie Fong; Elinne Becket; Jessica Yuan; Cindy Tamae; Leah Medrano; Maria Maiz; Christine Wahba; Catherine Lee; Kim Lee; Katherine P Tran; Hanjing Yang; Robert M Hoffman; Anya Salih; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

3.  Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.

Authors:  Lisa Yun Song; Sara D'Souza; Karen Lam; Tina Manzhu Kang; Pamela Yeh; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

4.  Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code.

Authors:  Anne Liu; Lillian Tran; Elinne Becket; Kim Lee; Laney Chinn; Eunice Park; Katherine Tran; Jeffrey H Miller
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

5.  The evolution of class 1 integrons and the rise of antibiotic resistance.

Authors:  Michael Gillings; Yan Boucher; Maurizio Labbate; Andrew Holmes; Samyuktha Krishnan; Marita Holley; H W Stokes
Journal:  J Bacteriol       Date:  2008-05-16       Impact factor: 3.490

6.  Resistance redux. Infectious diseases, antibiotic resistance and the future of mankind.

Authors:  Julian Davies
Journal:  EMBO Rep       Date:  2008-07       Impact factor: 8.807

Review 7.  Call of the wild: antibiotic resistance genes in natural environments.

Authors:  Heather K Allen; Justin Donato; Helena Huimi Wang; Karen A Cloud-Hansen; Julian Davies; Jo Handelsman
Journal:  Nat Rev Microbiol       Date:  2010-03-01       Impact factor: 60.633

Review 8.  Julian Davies and the discovery of kanamycin resistance transposon Tn5.

Authors:  Douglas E Berg
Journal:  J Antibiot (Tokyo)       Date:  2016-10-12       Impact factor: 2.649

Review 9.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

10.  Tobramycin at subinhibitory concentration inhibits the RhlI/R quorum sensing system in a Pseudomonas aeruginosa environmental isolate.

Authors:  Fedora Babić; Vittorio Venturi; Gordana Maravić-Vlahovicek
Journal:  BMC Infect Dis       Date:  2010-06-02       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.